January 20, 2022
Immunity, Inflammation and Disease
Shahjalal University of Science & Technology (Bangladesh)
"2.7 Analysis of the effectiveness of promising drugs
We analyzed 10 promising drugs targeting the main (3CL) protease protein of SARS-CoV-2 including Nirmatrelvir, Ritonavir, Ivermectin, Lopinavir, Boceprevir, 13b, N3, GC-373, GC376, and PF-00835231...
From our study, Ivermectin showed the highest binding affinity, suggesting to be the most effective drug candidate against the Omicron variant."
© 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
document
COVID-19,ivermectin,medical treatments,pharmaceuticals